Flow cytometry showed that the ratios of tumor-infiltrating CD4+ and CD8+ T lymphocytes were significantly elevated in the CXCL13-overexpressing tumor, compared with parental 4T1 and 4T1-pCDH (Fig. 5A, B). This evidence concerns the gene CD4 and neoplasm.